MoneyWorks4Me

Orchid Pharma - Quaterly Results

04 Nov 2023 Evaluate
The company witnessed a 20.28% growth in the revenue at Rs. 1987.55 millions for the quarter ended September 2023 as compared to Rs. 1652.50 millions during the year-ago period.The Total Profit for the quarter ended September 2023 of Rs. 202.42 millions grew from Rs.-33.22 millionsThe company reported a good operating profit of 318.81 millions compared to 236.63 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 1987.55 1652.50 20.28 3816.75 2962.38 28.84 6658.98 5569.74 19.56
Other Income 81.82 58.40 40.10 100.68 87.71 14.79 194.31 90.03 115.83
PBIDT 318.81 236.63 34.73 559.09 390.44 43.19 1030.49 662.62 55.52
Interest 37.98 92.21 -58.81 93.43 170.61 -45.24 322.26 320.12 0.67
PBDT 280.83 144.42 94.45 465.66 219.83 111.83 1100.33 342.50 221.26
Depreciation 78.41 177.64 -55.86 155.49 393.93 -60.53 547.86 870.21 -37.04
PBT 202.42 -33.22 -709.33 310.17 -174.10 -278.16 552.47 -527.71 -204.69
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 202.42 -33.22 -709.33 310.17 -174.10 -278.16 552.47 -527.71 -204.69
Equity 507.19 408.16 24.26 507.19 408.16 24.26 408.16 408.16 0.00
PBIDTM(%) 16.04 14.32 12.02 14.65 13.18 11.14 15.48 11.90 30.08
Peers
Company Name CMP
Sun Pharma. Inds. 1851.50
Dr. Reddys Labs. 1140.50
Cipla 1357.95
Lupin 2041.60
Zydus Lifesciences 1098.40
View more..